Epigenetic effects of lung cancer predisposing factors impact on clinical diagnosis and prognosis
Authors:
- Christina PiperiChristina Piperi
- Fotis VlastosFVFotis Vlastos
- Elena FarmakiEFElena Farmaki
- Nadine MartinetNMNadine Martinet
- Athanasios G. PapavassiliouAthanasios G. Papavassiliou
Open Access
- 1 September 2008
- journal article
- review article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 12 (5a) , 1495-1501
Abstract
Lung carcinogenesis is a complex process requiring the acquisition of genetic mutations that confer the malignant phenotype as well as epigenetic alterations that may be both manipulated in the course of therapy. Aberrant gene function and transcriptional silencing by CpG island hypermethylation has become a critical component in the initiation and progression of lung cancer. Growing evidence shows that acquired epigenetic abnormalities participate with genetic alterations to cause this dysregulation. Human and animal studies have fostered significant advances in elucidating the role of gene-specific methylation in cancer initiation and progression, the modulation of DNA methylation by carcinogen exposure and the ability of pharmacologic agents to reverse promoter hypermethylation, making it an attractive target to pursue for prevention of lung cancer. This review focuses on how lung cancer predisposing factors participate in epigenetic alterations of lung neoplasia, and discusses the growing implications of these alterations for strategies to control cancer.Keywords
This publication has 40 references indexed in Scilit:
- Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serumBritish Journal of Cancer, 2007
- Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinomaCancer, 2006
- Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genesCancer Genetics and Cytogenetics, 2005
- Assessing abnormal gene promoter methylation in paraffin-embedded sputum from patients with NSCLCEuropean Journal of Cancer, 2005
- CpG island methylation and expression of tumour-associated genes in lung carcinomaEuropean Journal of Cancer, 2005
- Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancerCarcinogenesis, 2005
- Hypermethylation of RASSF1A and BLU tumor suppressor genes in non‐small cell lung cancer: Implications for tobacco smoking during adolescenceInternational Journal of Cancer, 2004
- Plutonium targets the p16 gene for inactivation by promoter hypermethylation in human lung adenocarcinomaCarcinogenesis, 2004
- Carcinogen exposure differentially modulates RAR- promoter hypermethylation, an early and frequent event in mouse lung carcinogenesisCarcinogenesis, 2003
- Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavy smokersInternational Journal of Cancer, 2003